Impact Biomedical (IBO) Current Assets (2022 - 2026)
Impact Biomedical (IBO) posted Current Assets of $377000.0 for Q1 2026, down 8.27% on a QoQ basis from $411000.0 in Q4 2025, and down 82.73% year-over-year from $2.2 million in Q1 2025.
Impact Biomedical (IBO) Current Assets (2022 - 2026) Analysis & Trends
Impact Biomedical's Current Assets history runs 5 years deep, the most recent figure standing at $377000.0 for Q1 2026.
- Quarterly Current Assets fell 82.73% year-over-year to $377000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $377000.0 (down 82.73% YoY) and the FY2025 annual result came in at $411000.0, down 83.21% from the prior year.
- Current Assets was $377000.0 for Q1 2026 at Impact Biomedical, down from $411000.0 in the prior quarter.
- Across five years, Current Assets topped out at $3.2 million in Q3 2024 and bottomed at $122000.0 in Q4 2022.
- A 5-year average of $995153.8 and a median of $411000.0 in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets surged 637.35% — and 2025, when it plunged 83.21%.
- Impact Biomedical's Current Assets stood at $122000.0 in 2022, then soared by 172.13% to $332000.0 in 2023, then jumped by 637.35% to $2.4 million in 2024, then plunged by 83.21% to $411000.0 in 2025, then fell by 8.27% to $377000.0 in 2026.
- Business Quant data shows IBO's Current Assets at $377000.0 in Q1 2026, $411000.0 in Q4 2025, and $917000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 377,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 377,000.00 |
| Dec 31, 2025 | 411,000.00 |
| Sep 30, 2025 | 917,000.00 |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | 307,000.00 |
| Mar 31, 2024 | 335,000.00 |
| Dec 31, 2023 | 332,000.00 |
| Sep 30, 2023 | 501,000.00 |
| Jun 30, 2023 | 348,000.00 |
| Dec 31, 2022 | 122,000.00 |